Brief: Lee's Pharmaceutical Holdings Sells 45.5 Pct Stake In China Ophthalmology Focus
23/05/2019 15:21
May 23 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* COMPANY AGREED TO ISSUE AND SELL AGGREGATE OF 334,280
SERIES A
PREFERRED SHARES AT CONSIDERATION OF US$50 MILLION
* PREFERRED SHARES TO BE ISSUED REPRESENT ABOUT 45.525% OF
EQUITY
SHARE CAPITAL OF CHINA OPHTHALMOLOGY FOCUS LTD
Source text for Eikon: urn:newsml:reuters.com:*:nHKS5c3NHh
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals